Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Sunday morning. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Trading Up 9.2 %

NASDAQ:RKDA opened at $3.43 on Friday. The stock has a 50-day moving average price of $4.27 and a 200 day moving average price of $4.13. The stock has a market capitalization of $4.68 million, a P/E ratio of -0.80 and a beta of 0.86. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $10.31.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences at the end of the most recent quarter. 17.73% of the stock is owned by institutional investors and hedge funds.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.